Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

TheyWorkForYou

Menu

NHS: Infectious Diseases

Health written question – answered on 21st May 2008.

Alert me about debates like this

Photo of Philip Davies Philip Davies Conservative, Shipley

To ask the Secretary of State for Health under what circumstances a product or treatment may bypass a Rapid Review Panel assessment; and which (a) products and (b) treatments did so in each of the last three years for which information is available.

Photo of Ann Keen Ann Keen Parliamentary Under-Secretary (Health Services), Department of Health

The Rapid Review Panel (RRP) was convened by the Health Protection Agency (HPA) at the request of the Department. The RRP's role, as defined by the HPA and the Department, is

'to provide a prompt assessment of new and novel equipment, materials and other products or protocols that may be of value to the national health service in improving hospital infection control and reducing hospital acquired infections'.

Products do not bypass the RRP although some may fall outside the remit of the RRP.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.